clinical trial · NCT03974932
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
AnalgesiaHTX-011IbuprofenAcetaminophenCelecoxib+/- Bupivacaine HClLuer Lock ApplicatorHTX-011
brief summary
Phase 3b, open-label single-arm study in which all subjects receive HTX-011 as part of a scheduled non-opioid MMA regimen.
started
Jun 5, 2019
primary completion
Dec 7, 2020
completion
Jan 7, 2021
last updated
Mar 2, 2026
official title
A Phase 3b, Open-Label Study of HTX-011 as Part of a Scheduled Non-Opioid Multimodal Analgesic Regimen in Subjects Undergoing Total Knee Arthroplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol